In this issue of Blood, Leon and colleagues describe the effects of romiplostim, athrombopoietin (Tpo) mimetic peptide, in the mouse model of inherited platelet dysfunction because of mutation of the myosin 9 gene.1
| UI | MeSH Term | Description | Entries |
|---|
In this issue of Blood, Leon and colleagues describe the effects of romiplostim, athrombopoietin (Tpo) mimetic peptide, in the mouse model of inherited platelet dysfunction because of mutation of the myosin 9 gene.1
| UI | MeSH Term | Description | Entries |
|---|